VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edderd who wrote (18676)	2/11/1999 6:26:00 PM
From: VLAD	Read Replies (2) of 23519

Ed, You are wrong on that one. The board approved a purchase of up to 2 million shares back in the spring of 1997. Vivus bought back about 300k shares soon after that in mid 1997 for an average price of over $22.00/share. Then in Q1 1998 they bought the remaining 1.7M shares allowed at an average price of over $14.00/share. Vivus thought that their stock was worth at least $14.00/share in early 1998 even when they knew that Viagra may verry well be approved a few months later. I believe that this factor alone would make it difficult for Vivus to ever justify selling the company for anything less than $14.00/share and I feel that even that price is too low. The other day I was listening to a report on the cost of developing new drugs and they said that only one in 100 ever makes it to market. Up to 500 million can be spent on a drug that may never gain approval. Whose not to like Vivus at 2 1/2 for a market cap of less than 80 million when they have a proven safe and effective product that is just now starting to be marketed in new global markets. This stock IMO is just a sick joke at current valuations.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next